Antios Therapeutics

company

About

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$75M
Industries
Biopharma,Biotechnology,Therapeutics
Founded date
Jan 1, 2018
Number Of Employee
11 - 50
Operating Status
Active

Antios Therapeutics is a biopharmaceutical company devoted to developing innovative therapies for viral diseases. With an experienced and proven leadership team, the company is focused on the development of its oral drug candidate for potentially curative treatment of HBV infections.

Antios Therapeutics was founded by Abel De La Rosa, Douglas Mayers, and Idean Marvasty.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$75M
Antios Therapeutics has raised a total of $75M in funding over 2 rounds. Their latest funding was raised on Nov 3, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 3, 2021 Series B $75M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Antios Therapeutics is funded by 2 investors. Heartland Healthcare Capital and Avego Bioscience Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Heartland Healthcare Capital Series B
Avego Bioscience Capital Series B